TREM1 and neoplasm: Thus, these data demonstrate that while TREM-1 blockade alone either with GF9 or GA31-LPC is effective in suppressing tumor progression, only GA31-LPC, but not GF9 could overcome tumor resistance to PD-L1 blockade and synergize with immunotherapy.